CDC IRB Approval of Continuation of Protocol #5032.0,

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

CDC IRB Approval of Continuation of Protocol #5032.0, " IND: Intravenous Artesunate for Treatment of Severe Malaria in the United States” (Convened)

10/18/2019

[PDF-123.12 KB]

Details You May Also Like

Details:

Description:

CDC's IRB S has reviewed and approved your request to continue protocol #5032.0 for the maximum allowable period of one year. C
Document Type:

FactSheet
CIO:

CGH
Division:

CGH_DPDM
Location:

North America
Collection(s):

Historical CDC.gov Content
Main Document Checksum:

[+]

urn:sha256:89c7b69d1d4cd8cdca10715a68b406f31dc2485036546e66ab322d3381727560
Download URL:

https://stacks.cdc.gov/view/cdc/152652/cdc_152652_DS1.pdf
File Type:

No Additional Files

More +

CDC IRB Approval of Continuation of Protocol #5032.0, " IND: Intravenous Artesunate for Treatment of Severe Malaria in the United States” (Convened)

Details:

Supporting Files

You May Also Like